Radiochemical pharmacokinetic profile of P10 peptide with antifungal properties

Area of Science:

• Mycology
• Immunology
• Radiochemistry

Background:

• Paracoccidioidomycosis (PCM) is a significant fungal infection endemic to Latin America, caused by Paracoccidioides brasiliensis.
• The peptide P10 has demonstrated immune protection in experimental PCM models.
• Understanding the in vivo behavior of P10 is crucial for therapeutic development.

Purpose of the Study:

• To radiolabel the P10 peptide for in vivo pharmacokinetic evaluation.
• To assess the biodistribution and excretion pathways of radiolabeled P10.
• To explore the potential of P10 as a prophylactic agent or vaccine component for PCM.

Main Methods:

• Radiolabeling of the P10 peptide with a radioisotope.
• In vivo evaluation of pharmacokinetics, biodistribution, and scintigraphic imaging in animal models.
• Analysis of blood clearance, organ uptake, and excretion routes.

Main Results:

• The radiolabeling process achieved high radiochemical purity.
• Biodistribution studies revealed rapid blood clearance, primarily via renal excretion, with significant hepatobiliary excretion.
• Marked uptake of the radiolabeled peptide was observed in cervical lymph nodes.

Conclusions:

• The pharmacokinetic profile of radiolabeled P10 suggests favorable biodistribution characteristics.
• The observed uptake in lymph nodes and excretion pathways indicate potential for targeted delivery or immune interaction.
• These findings support the further development of P10 for prophylactic strategies against Paracoccidioidomycosis.